De Blieck; Ann

Patent Applications and Registrations

Patent applications and USPTO patent grants for De Blieck; Ann.The latest application filed is for "chimeric proteins and methods to screen for compounds and ligands binding to gpcrs".

Company Profile

2.9.8

De Blieck; Ann - Sinaai BE
de Blieck; Ann - Mechelen BE
De Blieck; Ann - Ninove BE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Chimeric Proteins And Methods To Screen For Compounds And Ligands Binding To Gpcrs App 20220276244 - De Blieck; Ann ; et al.	2022-09-01
N-sulfonylated-pyrazolo[3,4-b]pyridin-6-carboxamides and method of use Grant 10,647,717 - Akkari , et al.	2020-05-12
N-Sulfonylated-Pyrazolo[3,4-b]Pyridin-6-Carboxamides and Method of Use App 20190330207 - Akkari; Rhalid ; et al.	2019-10-31
N-SULFONYLATED PYRAZOLO[3,4-b]PYRIDIN-6-CARBOXAMIDES AND METHOD OF USE App 20190202823 - Akkari; Rhalid ; et al.	2019-07-04
N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of use Grant 10,259,810 - Akkari , et al.	2019-04-16
N-SULFONYLATED PYRAZOLO[3,4-b]PYRIDIN-6-CARBOXAMIDES AND METHOD OF USE App 20180105522 - Akkari; Rhalid ; et al.	2018-04-19
N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of use Grant 9,890,158 - Akkari , et al. February 13, 2	2018-02-13
Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis Grant 9,867,806 - De Blieck , et al. January 16, 2	2018-01-16
N-SULFONYLATED PYRAZOLO[3,4-b]PYRIDIN-6-CARBOXAMIDES AND METHOD OF USE App 20170101405 - Akkari; Rhalid ; et al.	2017-04-13
Novel Compounds And Pharmaceutical Compositions Thereof For The Treatment Of Cystic Fibrosis App 20160263084 - De Blieck; Ann ; et al.	2016-09-15
Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis Grant 9,382,254 - De Blieck , et al. July 5, 2	2016-07-05
1-substituted 2-azabicyclo [3.1.1] heptyl derivatives useful as nicotinic acetylcholine receptor modulators for treating neurologic disorders Grant 8,809,365 - Stevens , et al. August 19, 2	2014-08-19
Substituted 7-azabicyclo[2.2.1]heptyl derivatives useful for making pharmaceutical compositions Grant 8,389,561 - Stevens , et al. March 5, 2	2013-03-05
1-substituted 2-azabicyclo [3.1.1] Heptyl Derivatives Useful As Nicotinic Acetylcholine Receptor Modulators For Treating Neurologic Disorders App 20120245196 - Stevens; Christian ; et al.	2012-09-27
Substituted 7-azabicyclo[2.2.1]heptyl Derivatives Useful For Making Pharmaceutical Compositions App 20100093807 - STEVENS; Christian ; et al.	2010-04-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.